Efficacy and Safety of Atezolizumab and Bevacizumab in the Real-World Treatment of Advanced Hepatocellular Carcinoma: Experience from Four Tertiary Centers

SIMPLE SUMMARY: Hepatocellular carcinoma is one of the most common cancers in the world with increasing incidence. In advanced stages, according to the Barcelona Clinic Liver Cancer (BCLC) staging defined by number, size, vessel infiltration status, and patient’s performance status, the therapy of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Himmelsbach, Vera, Pinter, Matthias, Scheiner, Bernhard, Venerito, Marino, Sinner, Friedrich, Zimpel, Carolin, Marquardt, Jens U., Trojan, Jörg, Waidmann, Oliver, Finkelmeier, Fabian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996828/
https://www.ncbi.nlm.nih.gov/pubmed/35406493
http://dx.doi.org/10.3390/cancers14071722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996828/
https://www.ncbi.nlm.nih.gov/pubmed/35406493
http://dx.doi.org/10.3390/cancers14071722

Ejemplares similares